UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH)

Journal of viral hepatitis, 2023-11, Vol.30 (11), p.897-900

2023

Link zum Volltext

Verfügbarkeit prüfen

Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)

Journal of viral hepatitis, 2020-12, Vol.27 (12), p.1462-1472

2020

Link zum Volltext

Verfügbarkeit prüfen

HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)

AIDS and behavior, 2021-12, Vol.25 (12), p.4141-4153

2021

Link zum Volltext

Verfügbarkeit prüfen

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)

Nutrients, 2020-08, Vol.12 (9), p.2532

2020

Link zum Volltext

Verfügbarkeit prüfen

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

Blood, 2001-10, Vol.98 (8), p.2339-2344

2001

Link zum Volltext

Verfügbarkeit prüfen

Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients

PloS one, 2018-07, Vol.13 (7), p.e0199874

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

AIDS (London), 2010-09, Vol.24 (14), p.2211-2223

2010

Link zum Volltext

Verfügbarkeit prüfen

Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users

Addiction (Abingdon, England), 2012-01, Vol.107 (1), p.152-159

2012

Link zum Volltext

Verfügbarkeit prüfen

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-12, Vol.292 (23), p.2839

2004

Link zum Volltext

Verfügbarkeit prüfen

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Journal of antimicrobial chemotherapy, 2019-09, Vol.74 (9), p.2742-2751

2019

Link zum Volltext

Verfügbarkeit prüfen

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

Journal of acquired immune deficiency syndromes (1999), 2004-03, Vol.35 (3), p.269

2004

Link zum Volltext

Verfügbarkeit prüfen

Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study

The Journal of infection, 2020-10, Vol.81 (4), p.614-620

2020

Link zum Volltext

Verfügbarkeit prüfen

Vaccine knowledge in students in Paris, France, and surrounding regions

The Canadian journal of infectious diseases & medical microbiology, 2014, Vol.25 (3), p.141-146

2014

Link zum Volltext

Verfügbarkeit prüfen

Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial

Fundamental & clinical pharmacology, 2009-08, Vol.23 (4), p.491-500

2009

Link zum Volltext

Verfügbarkeit prüfen

Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus

British journal of haematology, 2004-06, Vol.125 (6), p.769-776

2004

Link zum Volltext

Verfügbarkeit prüfen

Interaction between HIV-1 and HCV infections: towards a new entity?

Journal of antimicrobial chemotherapy, 2004-06, Vol.53 (6), p.936-946

2004

Link zum Volltext

Verfügbarkeit prüfen

No significant effect of cannabis use on the count and percentage of circulating CD4 T‐cells in HIV‐HCV co‐infected patients (ANRS CO13‐HEPAVIH French cohort)

Drug and alcohol review, 2017-03, Vol.36 (2), p.227-238

2017

Link zum Volltext

Verfügbarkeit prüfen

Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13‐HEPAVIH cohort

Addiction (Abingdon, England), 2017-09, Vol.112 (9), p.1669-1679

2017

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of azithromycin prophylaxis during a pertussis outbreak among healthcare workers in a university hospital in Paris

Infection control and hospital epidemiology, 2006-06, Vol.27 (6), p.626

2006

Link zum Volltext

Verfügbarkeit prüfen

Viral Hepatitis: Chronic Hepatitis C

1st ed. 2019., 2019

Link zum Volltext

Verfügbarkeit prüfen

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection

Journal of the International AIDS Society, 2022-12, Vol.25 (12), p.e26048-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Serum alpha-fetoprotein predicts virologic response to Hepatitis C treatment in HIV coinfected patients

AIDS (London), 2008-07, Vol.22 (12), p.1513-1515

2008

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “Coffee consumption and decreased all-cause mortality – What is the true estimate of effect?”

Journal of hepatology, 2018-05, Vol.68 (5), p.1106-1106

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

Liver international, 2014-07, Vol.34 (6), p.869-889

2014

Link zum Volltext

Verfügbarkeit prüfen

Integrating Human Immunodeficiency Virus–Specific Elements in the Treatment of Tobacco Dependence (ANRS 144 Inter-ACTIV)

Clinical infectious diseases, 2022-11, Vol.75 (10), p.1868-1871

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH)

Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)

HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)

Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH)

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients

Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial

Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases

Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study

Vaccine knowledge in students in Paris, France, and surrounding regions

Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial

Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus

Interaction between HIV-1 and HCV infections: towards a new entity?

No significant effect of cannabis use on the count and percentage of circulating CD4 T‐cells in HIV‐HCV co‐infected patients (ANRS CO13‐HEPAVIH French cohort)

Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13‐HEPAVIH cohort

Feasibility of azithromycin prophylaxis during a pertussis outbreak among healthcare workers in a university hospital in Paris

Viral Hepatitis: Chronic Hepatitis C

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection

Serum alpha-fetoprotein predicts virologic response to Hepatitis C treatment in HIV coinfected patients

Reply to: “Coffee consumption and decreased all-cause mortality – What is the true estimate of effect?”

Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1

Integrating Human Immunodeficiency Virus–Specific Elements in the Treatment of Tobacco Dependence (ANRS 144 Inter-ACTIV)

Suchergebnisse filtern